Apremilast is a new phosphodiesterase type 4 inhibitor that blocks the synthesis of proinflammatory cytokines and chemokines, such as tumor necrosis factor, interferon ??, and the interleukins(IL) IL-2, IL-12, and IL-23.2 These cytokines are important in the initiation and perpetuation of sarcoidosis.